Amanda Smith joined Rebus Biosystems as Vice President, Human Resources in March 2022, bringing more than 20 years’ experience in human resources and communications. Most recently, Amanda was Senior Director, Human Resources for Santa Cruz Nutritionals. Amanda began her career in the news media before transitioning to corporate communications at Circuit City, Inc. She moved […]
Eric Williams joined Rebus Biosystems as Chief Financial Officer in 2022. He brings over 30 years of cross-functional experience in high tech businesses from start-ups to large scale public companies. Prior to joining Rebus Biosystems, Eric has served as CFO in a variety of high-tech companies including NovalSignal, Evidation Health, Mimosa and Soraa. In addition, […]
Tom Willis has been an entrepreneur in the genomics industry for the past 15 years during which time he founded and successfully exited two startups in the genomic tools and diagnostic space. After having received his undergraduate and graduate degrees in physics from Yale and Stanford respectively, he directed technology development efforts at the Stanford […]
Gloria Chui joined Rebus Biosystems as Principal Scientist, Reagent Products in 2021. She brings 25 years of research and development experience in biochemistry, genomics and IVD product development to the company. Gloria is responsible for the development of chemistry and reagent product consumables for the Rebus Esper High Fidelity Assay platforms. Prior to joining Rebus, she was Staff Scientist at Applied Biosystems and Guardant Health leading […]
Hojin Lee joined Rebus Biosystems in 2010 and is now Director of Engineering. He is responsible for the system and software engineering of Rebus Bio’s imaging system. Since he joined the company, Hojin has been contributing to improvements in the company’s proprietary SAO technology as well as system automation. Hojin previously worked at the Samsung Advanced Institute of Technology of Samsung Electronics where […]
Simone Codeluppi joined Rebus Biosystems as Principal Scientist, Bioinformatics in 2021. Prior to that he was an Assistant Professor at the Karolinska Institutet in Stockholm, Sweden. During his time at the Karolinska Institutet he led a team focused on the development and automation of single molecule fluorescence hybridization (smFISH) technologies. Simone earned his PhD in Molecular Pathology from the University of California, San Diego […]
Neil Kennedy joined Rebus Biosystems as Chief Commercial Officer in January 2021, bringing 25 years commercial experience in the life science industry with a proven track record of developing and commercializing transformational products and services for the basic, translational and clinical research markets. Most recently, Neil was Senior Vice President Commercial Operations at Dovetail Genomics. […]
Ryu is the co-founder and Chief Technology Officer of Rebus Biosystems. During his time at MIT, he was one of the original developers of the company’s core technology, Synthetic Aperture Optics (SAO). Josh co-founded Rebus Biosystems in 2006 and served as the company’s Chief Executive Officer from its founding through 2020 when he took on […]